AXIM BIOTECHNOLOGIES, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-1.1M | $-1.1M | — | $287.5K |
| Jun 2020 | $-737.1K | $-737.1K | — | $0 |
| Sep 2020 | $-790.2K | $-790.2K | — | $491.5K |
| Dec 2020 | $-614.9K | $-614.9K | — | $1.5M |
| Mar 2021 | $-565.5K | $-565.5K | — | $99.7K |
| Jun 2021 | $-595.5K | $-595.5K | — | $91.5K |
| Sep 2021 | $-532.8K | $-532.8K | — | $761.8K |
| Dec 2021 | $-792.9K | $-792.9K | — | $190.7K |
| Mar 2022 | $-703.7K | $-703.7K | — | $188.9K |
| Jun 2022 | $-703.9K | $-703.9K | — | $182.2K |
| Sep 2022 | $-321.2K | $-321.2K | — | $517.2K |
| Dec 2022 | $-315.5K | $-315.5K | — | $219.2K |
| Mar 2023 | $-142.0K | $-142.0K | — | $103.8K |
| Jun 2023 | $-643.6K | $-643.6K | — | $21.4K |
| Sep 2023 | $-264.5K | $-264.5K | — | $38.4K |
| Dec 2023 | $19.6K | $19.6K | — | $34.1K |
| Mar 2024 | $-252.5K | $-255.3K | $2.8K | $9.6K |
| Jun 2024 | $-261.5K | $-261.5K | — | $9.6K |